WO2001062369A2 - Compositions utilisables pour l'hydratation d'un support d'electrophorese, pour l'electrophorese de zone - Google Patents
Compositions utilisables pour l'hydratation d'un support d'electrophorese, pour l'electrophorese de zone Download PDFInfo
- Publication number
- WO2001062369A2 WO2001062369A2 PCT/FR2001/000478 FR0100478W WO0162369A2 WO 2001062369 A2 WO2001062369 A2 WO 2001062369A2 FR 0100478 W FR0100478 W FR 0100478W WO 0162369 A2 WO0162369 A2 WO 0162369A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- electrophoresis
- sample
- composition according
- acid
- concentration
- Prior art date
Links
- 238000001962 electrophoresis Methods 0.000 title claims abstract description 75
- 239000000203 mixture Substances 0.000 title claims abstract description 44
- 238000007693 zone electrophoresis Methods 0.000 title description 4
- 230000000887 hydrating effect Effects 0.000 title description 2
- 239000000470 constituent Substances 0.000 claims abstract description 20
- 238000000034 method Methods 0.000 claims abstract description 18
- 230000036571 hydration Effects 0.000 claims abstract description 13
- 238000006703 hydration reaction Methods 0.000 claims abstract description 13
- 150000008040 ionic compounds Chemical class 0.000 claims abstract description 13
- 230000005684 electric field Effects 0.000 claims abstract description 12
- 230000006835 compression Effects 0.000 claims abstract description 9
- 238000007906 compression Methods 0.000 claims abstract description 9
- 230000008569 process Effects 0.000 claims abstract description 8
- 239000000499 gel Substances 0.000 claims description 35
- 230000005012 migration Effects 0.000 claims description 22
- 238000013508 migration Methods 0.000 claims description 22
- 238000000151 deposition Methods 0.000 claims description 18
- 150000001875 compounds Chemical class 0.000 claims description 15
- 230000008021 deposition Effects 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 235000001014 amino acid Nutrition 0.000 claims description 12
- 229940024606 amino acid Drugs 0.000 claims description 12
- 150000001413 amino acids Chemical class 0.000 claims description 12
- 239000011543 agarose gel Substances 0.000 claims description 10
- 238000005370 electroosmosis Methods 0.000 claims description 9
- 150000003839 salts Chemical class 0.000 claims description 9
- 238000000926 separation method Methods 0.000 claims description 9
- DVLFYONBTKHTER-UHFFFAOYSA-N 3-(N-morpholino)propanesulfonic acid Chemical compound OS(=O)(=O)CCCN1CCOCC1 DVLFYONBTKHTER-UHFFFAOYSA-N 0.000 claims description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- 239000000872 buffer Substances 0.000 claims description 6
- 230000000694 effects Effects 0.000 claims description 6
- HRGUSFBJBOKSML-UHFFFAOYSA-N 3',5'-di-O-methyltricetin Chemical compound COC1=C(O)C(OC)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 HRGUSFBJBOKSML-UHFFFAOYSA-N 0.000 claims description 5
- IDDMFNIRSJVBHE-UHFFFAOYSA-N Piscigenin Natural products COC1=C(O)C(OC)=CC(C=2C(C3=C(O)C=C(O)C=C3OC=2)=O)=C1 IDDMFNIRSJVBHE-UHFFFAOYSA-N 0.000 claims description 5
- KCFYHBSOLOXZIF-UHFFFAOYSA-N dihydrochrysin Natural products COC1=C(O)C(OC)=CC(C2OC3=CC(O)=CC(O)=C3C(=O)C2)=C1 KCFYHBSOLOXZIF-UHFFFAOYSA-N 0.000 claims description 5
- BMCJATLPEJCACU-UHFFFAOYSA-N tricin Natural products COc1cc(OC)c(O)c(c1)C2=CC(=O)c3c(O)cc(O)cc3O2 BMCJATLPEJCACU-UHFFFAOYSA-N 0.000 claims description 5
- SXGZJKUKBWWHRA-UHFFFAOYSA-N 2-(N-morpholiniumyl)ethanesulfonate Chemical compound [O-]S(=O)(=O)CC[NH+]1CCOCC1 SXGZJKUKBWWHRA-UHFFFAOYSA-N 0.000 claims description 4
- ACERFIHBIWMFOR-UHFFFAOYSA-N 2-hydroxy-3-[(1-hydroxy-2-methylpropan-2-yl)azaniumyl]propane-1-sulfonate Chemical compound OCC(C)(C)NCC(O)CS(O)(=O)=O ACERFIHBIWMFOR-UHFFFAOYSA-N 0.000 claims description 4
- LVQFQZZGTZFUNF-UHFFFAOYSA-N 2-hydroxy-3-[4-(2-hydroxy-3-sulfonatopropyl)piperazine-1,4-diium-1-yl]propane-1-sulfonate Chemical compound OS(=O)(=O)CC(O)CN1CCN(CC(O)CS(O)(=O)=O)CC1 LVQFQZZGTZFUNF-UHFFFAOYSA-N 0.000 claims description 4
- XCBLFURAFHFFJF-UHFFFAOYSA-N 3-[bis(2-hydroxyethyl)azaniumyl]-2-hydroxypropane-1-sulfonate Chemical compound OCCN(CCO)CC(O)CS(O)(=O)=O XCBLFURAFHFFJF-UHFFFAOYSA-N 0.000 claims description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 4
- OWXMKDGYPWMGEB-UHFFFAOYSA-N HEPPS Chemical compound OCCN1CCN(CCCS(O)(=O)=O)CC1 OWXMKDGYPWMGEB-UHFFFAOYSA-N 0.000 claims description 4
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims description 4
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 4
- MKWKNSIESPFAQN-UHFFFAOYSA-N N-cyclohexyl-2-aminoethanesulfonic acid Chemical compound OS(=O)(=O)CCNC1CCCCC1 MKWKNSIESPFAQN-UHFFFAOYSA-N 0.000 claims description 4
- JOCBASBOOFNAJA-UHFFFAOYSA-N N-tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid Chemical compound OCC(CO)(CO)NCCS(O)(=O)=O JOCBASBOOFNAJA-UHFFFAOYSA-N 0.000 claims description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 4
- CCIVGXIOQKPBKL-UHFFFAOYSA-N ethanesulfonic acid Chemical compound CCS(O)(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-N 0.000 claims description 4
- 239000006177 biological buffer Substances 0.000 claims description 3
- 238000006073 displacement reaction Methods 0.000 claims description 3
- LEVVMZZBTOYKSC-UHFFFAOYSA-N 1-amino-4-hydroxybutane-2-sulfonic acid Chemical compound NCC(S(O)(=O)=O)CCO LEVVMZZBTOYKSC-UHFFFAOYSA-N 0.000 claims description 2
- IHPYMWDTONKSCO-UHFFFAOYSA-N 2,2'-piperazine-1,4-diylbisethanesulfonic acid Chemical compound OS(=O)(=O)CCN1CCN(CCS(O)(=O)=O)CC1 IHPYMWDTONKSCO-UHFFFAOYSA-N 0.000 claims description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 claims description 2
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 claims description 2
- NUFBIAUZAMHTSP-UHFFFAOYSA-N 3-(n-morpholino)-2-hydroxypropanesulfonic acid Chemical compound OS(=O)(=O)CC(O)CN1CCOCC1 NUFBIAUZAMHTSP-UHFFFAOYSA-N 0.000 claims description 2
- 239000008000 CHES buffer Substances 0.000 claims description 2
- 239000004471 Glycine Substances 0.000 claims description 2
- 239000007995 HEPES buffer Substances 0.000 claims description 2
- 235000019766 L-Lysine Nutrition 0.000 claims description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 claims description 2
- 229930064664 L-arginine Natural products 0.000 claims description 2
- 235000014852 L-arginine Nutrition 0.000 claims description 2
- 239000004472 Lysine Substances 0.000 claims description 2
- 239000007993 MOPS buffer Substances 0.000 claims description 2
- FSVCELGFZIQNCK-UHFFFAOYSA-N N,N-bis(2-hydroxyethyl)glycine Chemical compound OCCN(CCO)CC(O)=O FSVCELGFZIQNCK-UHFFFAOYSA-N 0.000 claims description 2
- YNLCVAQJIKOXER-UHFFFAOYSA-N N-[tris(hydroxymethyl)methyl]-3-aminopropanesulfonic acid Chemical compound OCC(CO)(CO)NCCCS(O)(=O)=O YNLCVAQJIKOXER-UHFFFAOYSA-N 0.000 claims description 2
- SEQKRHFRPICQDD-UHFFFAOYSA-N N-tris(hydroxymethyl)methylglycine Chemical compound OCC(CO)(CO)[NH2+]CC([O-])=O SEQKRHFRPICQDD-UHFFFAOYSA-N 0.000 claims description 2
- 239000007990 PIPES buffer Substances 0.000 claims description 2
- 208000034953 Twin anemia-polycythemia sequence Diseases 0.000 claims description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 2
- 239000007998 bicine buffer Substances 0.000 claims description 2
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical class OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 claims description 2
- 238000007865 diluting Methods 0.000 claims description 2
- 229960002885 histidine Drugs 0.000 claims description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N phenylalanine group Chemical group N[C@@H](CC1=CC=CC=C1)C(=O)O COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 2
- 230000008030 elimination Effects 0.000 claims 1
- 238000003379 elimination reaction Methods 0.000 claims 1
- 239000000523 sample Substances 0.000 description 42
- 239000003085 diluting agent Substances 0.000 description 13
- 210000002966 serum Anatomy 0.000 description 13
- 210000001520 comb Anatomy 0.000 description 9
- 235000018102 proteins Nutrition 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 102000015094 Paraproteins Human genes 0.000 description 7
- 108010064255 Paraproteins Proteins 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 238000004040 coloring Methods 0.000 description 4
- 239000012470 diluted sample Substances 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- IHZXTIBMKNSJCJ-UHFFFAOYSA-N 3-{[(4-{[4-(dimethylamino)phenyl](4-{ethyl[(3-sulfophenyl)methyl]amino}phenyl)methylidene}cyclohexa-2,5-dien-1-ylidene)(ethyl)azaniumyl]methyl}benzene-1-sulfonate Chemical compound C=1C=C(C(=C2C=CC(C=C2)=[N+](C)C)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S(O)(=O)=O)=C1 IHZXTIBMKNSJCJ-UHFFFAOYSA-N 0.000 description 3
- 229920000936 Agarose Polymers 0.000 description 3
- 239000004475 Arginine Substances 0.000 description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
- 235000009697 arginine Nutrition 0.000 description 3
- 239000012472 biological sample Substances 0.000 description 3
- 239000012982 microporous membrane Substances 0.000 description 3
- 230000009471 action Effects 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/416—Systems
- G01N27/447—Systems using electrophoresis
- G01N27/44704—Details; Accessories
- G01N27/44743—Introducing samples
Definitions
- Zone electrophoresis techniques in agarose gel allow the separation of the protein constituents contained in notably biological samples, such as serum, blood, urine, cerebrospinal fluid, etc.
- biological samples such as serum, blood, urine, cerebrospinal fluid, etc.
- the proteins deposited on the surface of the gel ionize and will migrate, under the effect of an electric field, at different speeds depending on their respective charge.
- the fineness of the bands obtained after electrophoresis corresponding to the separate constituents of the sample and therefore the resolving power of the technique depends mainly on the fineness of the deposition of the sample.
- sample applicators In order to improve the fineness of the deposit, different types of sample applicators can be used. These applicators, often called deposit combs, can come in different forms. They are illustrated in particular by the following devices:
- “Throat” combs the teeth of which bear a groove, the edges of which are parallel to the application plane, which makes it possible to recover a drop of biological sample by capillary action.
- the comb is then applied to the electrophoresis gel under the effect of its own weight.
- the teeth are then in contact with the gel surface and the sample transfers from the tooth to the gel.
- These combs can be made of a metallic or plastic material.
- the sample is taken by capillary action in the space delimited by the two strips and deposited on the gel in the same way as in the case of the throat comb.
- These combs can, like the previous ones, be made of a metallic or plastic material.
- Membrane combs whose teeth are made of microporous membrane. These combs are described in patents EP 0 493 996, US 5,464,515, US 5,405,516.
- the teeth are impregnated with the sample until the microporous membrane is saturated.
- the teeth of the comb are then brought into contact with the surface of the gel in the same way as in the two cases. precedents. In this case, the sample is deposited by diffusion of the proteins from the microporous membrane to the gel.
- the sample is usually diluted.
- the most generally used dilutions are from 1/3 to 1/10.
- the dilution is carried out in physiological water in order to maintain the solubilized proteins.
- the object of the invention is to provide a means of eliminating this trademark, whatever the type of applicator used.
- the deposit mark produced on the electrophoresis support can be eliminated or at least neutralized so that it does not affect the interpretation of the results obtained.
- After the electrophoresis by hydrating the electrophoresis support at the level of the sample deposition area compressed by the application of the sample applicator. This hydration must be carried out under conditions allowing the constituents and in particular the proteins contained in the test sample, to penetrate into this region of the electrophoresis support in order to undergo electrophoretic migration there.
- the area of the electrophoresis support compressed by the applicator used to deposit the sample must be rehydrated sufficiently quickly and efficiently, so that the constituents of the sample can penetrate into the electrophoresis support and undergo migration in the applied electric field.
- the hydration must occur in a duration interval corresponding to 10 to 20% of the time of the electrophoresis (the latter corresponding to the duration of application of the voltage at the terminals of the electrophoresis support), from the energization of the electrophoresis support.
- rehydration can occur more quickly, that is to say in a time less than 10% of the time of electrophoresis, from the power up.
- the inventors have identified certain compounds which, when introduced into the diluent of the sample and are therefore deposited at the same time as the sample on the electrophoresis support, are capable of removing the clear mark left by compression of the electrophoresis support. These compounds have the effect of eliminating or at least attenuating this clear mark from the first moments of electrophoretic migration, while this mark persists throughout the migration in the absence of said compounds.
- the subject of the invention is therefore a composition which can be used in a process for separating the constituents of a sample, by electrophoresis on a support electrophoresis, comprising one or more ionic compounds allowing, during the application of an electric field at the level of an electrophoresis support having negative surface charges, a hydration of the deposit zone of the sample to be separated , when this zone bears a compression mark resulting from the deposition of the sample. This compression results from the pressure exerted by the applicator on the support.
- the presence of negative surface charges at the level of the electrophoresis support indicates a non-zero electroendosmosis (or electroosmotic flow capacity).
- the compression of the electrophoresis support resulting from the deposition of the sample by means of the applicator can be observed with the naked eye and corresponds to a hollow mark in said support.
- a mark can for example be described as having the shape of a V, generally of a depth less than 100 ⁇ and having a width of approximately 1 mm between the two upper parts of the V for an electrophoresis support constituted by 0.8% agarose gel, when the pressure of the applicator is greater than 0.1 g / mm 2 .
- the ionic compounds used for the preparation of the composition of the invention can, depending on the case, move or on the contrary remain essentially immobile during the electrophoretic migration.
- the absence of displacement in the electric field is attributable either to the nature of the compound or to its concentration in the composition, or even to a combination of these elements.
- the concentration of ionic compounds present in the composition is determined according to the nature of these compounds , and in particular their capacity or not to migrate in the electrophoresis support after the application of the electric field. This concentration must be chosen so as to allow hydration, from the first moments of the electrophoretic migration, of the zone of deposit of the sample at the level of the electrophoresis support.
- the hydration or rehydration effect of the electrophoresis support sought which depends, as indicated above, on the nature of the ionic compounds used, can also be influenced by the composition of the electrophoresis support and in particular its electroendosmosis index.
- the electrophoresis support is an agarose gel
- agarose gels will be used. having a non-zero electro-osmotic flow capacity, for example corresponding to a relative mobility index, -mr greater than or equal to 0.07.
- the ionic compounds used in the context of the invention are dissolved to form the composition defined above. They are used at a determined concentration below their solubility limit.
- the composition comprises one or more ionic compounds chosen from those which do not undergo significant displacement in an electric field.
- these compounds allow the rehydration of the area of the compressed electrophoresis support, but do not migrate with the constituents of the sample during electrophoresis.
- the invention advantageously relates to a composition comprising one or more ionic compounds chosen from zwitterionic compounds.
- amino acids corresponding to the formula NH 2 -R-COOH in which R comprises an uncharged polar side chain will be used for the production of the composition according to the invention.
- the amino acids chosen can be amino acids corresponding to the formula NH 2 -R-COOH, in which R comprises a basic side chain.
- amino acids corresponding to one or other of the preceding definitions can be used alone or, where appropriate, as a mixture, optionally in mixture with other compounds, ionic or nonionic, which can be used to obtain rehydration of the electrophoresis support, when this support can undergo electroendosmosis.
- amino acid suitable for the preparation of the composition of the invention By way of example of an amino acid suitable for the preparation of the composition of the invention, mention will be made of: glycine (preferably at a concentration compatible with its solubility in water at 25 ° C. and in this respect, a concentration between 1 M and 3.33 M is usable), phenylalanine at a concentration of 0.28 M.
- Other examples are the amino acids chosen from L-lysine advantageously at a concentration greater than or equal to 1 M, L-arginine preferably at a concentration between 0.45 M and 0.86 M, L-histidine preferably at a concentration of 0.27 M.
- TRICIN N-tris ( hydroxymethyl) methyl-glycine
- MOPS 3- (N-Morpholino) propanesulfonic acid
- TAPS N-tris (Hydroxymethyl) methyl-3aminopropanesulfonic acid
- AMPSO (3 - ((1, 1-Dimethyl-2-hydroxyethyl) amino) -2-hydroxy-propanesulfonic acid)
- EPPS N- (2-Hydroxyethyl) piperazine-N '- (3-propanesulfonic acid)
- these salts can be chosen from NaCI, KCI or NaHCO 3 at a concentration greater than or equal to 1 M or a boric acid salt at a concentration greater than or equal to 0.15 M or a salt of phosphoric acid, or acetic acid at a concentration greater than or equal to 0.5 M.
- the subject of the invention is therefore the use of a composition corresponding to one of the definitions given above, or to several of these definitions taken in combination, for the hydration of an electrophoresis support, at the level of the sample deposition zone to be separated by electrophoresis.
- This use can be made in the form of a dilution of the sample to be separated by electrophoresis using the composition according to the invention.
- the invention also relates to a kit intended for the implementation of a process of separation by electrophoresis, of the constituents of a sample, characterized in that it comprises: - a composition defined above, - a support electrophoresis consisting of a gel having a non-zero electro-osmotic flow.
- a kit thus defined can also include any other reagent or device usually present in electrophoresis kits, such as migration buffers, and the developers used to identify the constituents separated by electrophoresis from the sample.
- An electrophoresis support which can be used for carrying out the invention is generally a gel and in particular a gel having a non-zero electro-osmatic flow.
- agarose gels and in particular agarose gels HGT® or HEEO®, from the company FMC-BIOWHITTAKER or agaroses LE® or SHE® from the company HISPANAGAR or their mixtures.
- agarose gels have the property of exhibiting non-zero electroendosmosis.
- the agarose gels used to prepare the electrophoresis supports according to the invention have a concentration of 0.8 to 1% in agarose, and can contain agaroses in a mixture.
- the invention also relates to a method of separation by electrophoresis of the constituents of a sample comprising:
- the revelation can be carried out by means of dyes and in the case of immunofixation, by means of antisera and dyes.
- the previously defined process can be implemented according to the usual methods of electrophoresis and can in particular comprise, for the revelation of the constituents separated by electrophoresis, an immunofixation procedure.
- the method according to the invention implementing the composition defined above can be effectively used to detect the presence of paraproteins in a biological sample.
- This process can be implemented advantageously in the context of zone electrophoresis separation.
- the simultaneous deposition of the sample and of the composition of the invention allows the rehydration of the gel in the very first moments of the electrophoretic migration.
- the sample and the composition of the invention can be combined, if necessary, before their deposition on the electrophoresis support, in particular by diluting the sample in the composition.
- Example 1 Typing of serum paraproteins diluted in a tricin solution (0.45 M), on an immunofixation gel.
- tricin dissolved in 4 ml of water.
- the diluent thus formed is ready for use.
- the serum sample to be typed was diluted in the diluent by a third for the track corresponding to the electrophoretic profile, as well as for the tracks IgA, IgM, IgK and Ig ⁇ (for example, 30 ⁇ l of serum and 60 ⁇ l of diluent) and sixth for the IgG revelation track (for example, 20 ⁇ l of serum and 100 ⁇ l of diluent).
- the typing of the paraproteins was carried out by incubating each migration track with a specific antiserum (anti IgG, anti IgA, anti IgM, anti IgK, anti Ig ⁇ ) and the track corresponding to the electrophoretic profile with a protein binding solution. The excess reagent was removed, the gel was dried and stained with acid violet.
- a specific antiserum anti IgG, anti IgA, anti IgM, anti IgK, anti Ig ⁇
- Example 2 Typing of serum paraproteins diluted in a solution of Arginine (0.86 M), on an immunofixation gel.
- 0.6 g of L Arginine was dissolved in 4 ml of water in a test tube.
- the diluent thus formed is ready for use.
- the serum sample to be typed was diluted in the diluent by a third for the track corresponding to the electrophoretic profile, as well as for the tracks IgA, IgM, IgK and Ig ⁇ (for example, 30 ⁇ l of serum and 60 ⁇ l of diluent) and sixth for the IgG revelation track (for example, 20 ⁇ l of serum and 100 ⁇ l of diluent).
- 4 ml of physiological water was introduced which made it possible to dilute the same sample in an identical manner to the previous case.
- the applicator thus loaded was then applied to the surface of the IF gel for 1 minute.
- Example 3 Typing of serum paraproteins diluted in a solution of sodium chloride (1.2 M), on an immunofixation gel.
- the serum sample to be typed was diluted in the diluent by a third for the track corresponding to the electrophoretic profile, as well as for the tracks IgA, IgM, IgK and Ig ⁇ (for example, 30 ⁇ l of serum and 60 ⁇ l of diluent) and sixth for the IgG revelation track (for example, 20 ⁇ l of serum and 100 ⁇ l of diluent).
- the applicator thus loaded was then applied to the surface of the IF gel for 1 minute.
- the separation of these samples applied to the IF gel was obtained by electrophoresis for approximately 10 minutes and at a power of 20 W, on an instrument making it possible to regulate the temperature at 20 ° C.
- the typing of the paraproteins was carried out by incubating each migration track with a specific antiserum (anti IgG, anti IgA, anti IgM, anti IgK, anti Ig ⁇ ) and the track corresponding to the electrophoretic profile with a protein fixing solution. . The excess reagent was removed, the gel was dried and stained with acid violet.
- a specific antiserum anti IgG, anti IgA, anti IgM, anti IgK, anti Ig ⁇
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Electrochemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Electrostatic Separation (AREA)
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU35711/01A AU3571101A (en) | 2000-02-22 | 2001-02-16 | Compositions for hydrating an electrophoresis support to improve zone electrophoresis |
EP01907836A EP1207954A2 (fr) | 2000-02-22 | 2001-02-16 | Compositions utilisables pour l'hydratation d'un support d'electrophorese, pour l'electrophorese de zone |
JP2001561425A JP2003523525A (ja) | 2000-02-22 | 2001-02-16 | ゾーン電気泳動を改良するために電気泳動支持体を再水和させる組成物 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0002206A FR2805175B1 (fr) | 2000-02-22 | 2000-02-22 | Compositions utilisables pour l'hydratation d'un support d'electrophorese, pour l'amelioration de l'electrophorese de zone |
FR00/02206 | 2000-02-22 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001062369A2 true WO2001062369A2 (fr) | 2001-08-30 |
WO2001062369A3 WO2001062369A3 (fr) | 2002-03-14 |
Family
ID=8847266
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR2001/000478 WO2001062369A2 (fr) | 2000-02-22 | 2001-02-16 | Compositions utilisables pour l'hydratation d'un support d'electrophorese, pour l'electrophorese de zone |
Country Status (8)
Country | Link |
---|---|
US (2) | US6572746B1 (fr) |
EP (1) | EP1207954A2 (fr) |
JP (1) | JP2003523525A (fr) |
AR (1) | AR027339A1 (fr) |
AU (1) | AU3571101A (fr) |
FR (1) | FR2805175B1 (fr) |
TW (1) | TW572772B (fr) |
WO (1) | WO2001062369A2 (fr) |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3482943A (en) * | 1966-02-14 | 1969-12-09 | Miles Lab | Reagent deposition device |
US3932229A (en) * | 1974-11-15 | 1976-01-13 | Millipore Corporation | Method of sample application to gel electrophoresis media |
DE2614192C2 (de) * | 1976-04-02 | 1986-09-18 | FMC Corp., Wilmington, Del. | Analysenvorrichtung und Analysenverfahren |
GB8513152D0 (en) * | 1985-05-24 | 1985-06-26 | Ciba Geigy Ag | Diagnostic strips |
US4857163A (en) * | 1987-07-17 | 1989-08-15 | Beckman Instruments, Inc. | High resolution electrophoretic gel and method for separating serum proteins |
US5171410A (en) * | 1989-10-20 | 1992-12-15 | Helena Laboratories Corporation | Method and formulation for creating kinase isoform separation |
US5064519A (en) * | 1990-06-29 | 1991-11-12 | E. I. Du Pont De Nemours And Company | Neutral and positively charged dyes for electrophoresis sample loading solutions |
US5035287A (en) * | 1990-07-30 | 1991-07-30 | Oryz Energy Company | Redox gel process for more uniform fluid flow in formations |
US5405516A (en) | 1991-01-04 | 1995-04-11 | Sebia | Apparatus for the application of biological samples to an electrophoretic slab support |
FR2671290B1 (fr) | 1991-01-04 | 1993-04-16 | Sebia Sa | Dispositif pour l'application d'echantillons biologiques sur une plaque d'electrophorese. |
US5159049A (en) * | 1991-04-22 | 1992-10-27 | Allen Robert C | Method for stabilizing polyacrylamide gels |
US5503722A (en) * | 1994-02-28 | 1996-04-02 | Beckman Instruments, Inc. | Rehydratable gels for capillary electrophoresis |
US5498536A (en) * | 1994-04-22 | 1996-03-12 | American Cyanamid Company | Chondroitinase II from Proteus vulgaris |
US5840338A (en) * | 1994-07-18 | 1998-11-24 | Roos; Eric J. | Loading of biologically active solutes into polymer gels |
US5681437A (en) * | 1995-10-31 | 1997-10-28 | Isolab, Inc. | Sample deposition device |
US5683915A (en) * | 1995-10-31 | 1997-11-04 | Isolab, Inc. | Sample deposition device and method |
US5993627A (en) * | 1997-06-24 | 1999-11-30 | Large Scale Biology Corporation | Automated system for two-dimensional electrophoresis |
WO1999013987A1 (fr) * | 1997-09-16 | 1999-03-25 | Life Technologies, Inc. | Adaptateur de chargement de gel |
AUPP108697A0 (en) * | 1997-12-23 | 1998-01-22 | Macquarie Research Limited | Apparatus for electrophoresis |
US6232070B1 (en) * | 1998-11-09 | 2001-05-15 | Stewart Shuman | Pharmacological targeting of mRNA cap formation |
US6232076B1 (en) * | 2000-02-04 | 2001-05-15 | Genaissance Pharmaceuticals, Inc. | Stabilizer of dye sequencing products |
-
2000
- 2000-02-22 FR FR0002206A patent/FR2805175B1/fr not_active Expired - Fee Related
- 2000-06-07 US US09/589,008 patent/US6572746B1/en not_active Expired - Fee Related
-
2001
- 2001-01-31 AR ARP010100439A patent/AR027339A1/es unknown
- 2001-02-16 AU AU35711/01A patent/AU3571101A/en not_active Abandoned
- 2001-02-16 WO PCT/FR2001/000478 patent/WO2001062369A2/fr not_active Application Discontinuation
- 2001-02-16 EP EP01907836A patent/EP1207954A2/fr not_active Withdrawn
- 2001-02-16 JP JP2001561425A patent/JP2003523525A/ja active Pending
- 2001-02-21 TW TW90103911A patent/TW572772B/zh active
-
2002
- 2002-12-11 US US10/316,310 patent/US20030079988A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
TW572772B (en) | 2004-01-21 |
FR2805175A1 (fr) | 2001-08-24 |
AU3571101A (en) | 2001-09-03 |
AR027339A1 (es) | 2003-03-26 |
EP1207954A2 (fr) | 2002-05-29 |
JP2003523525A (ja) | 2003-08-05 |
FR2805175B1 (fr) | 2002-05-10 |
US20030079988A1 (en) | 2003-05-01 |
WO2001062369A3 (fr) | 2002-03-14 |
US6572746B1 (en) | 2003-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Frater | Artifacts in isoelectric focusing | |
EP0187586B1 (fr) | Perfectionnements aux procédés et appareils d'électrophorèse préparative | |
CN101799448B (zh) | 通过毛细管电泳分离蛋白质的方法和毛细管电泳用的缓冲组合物 | |
Lloyd et al. | Sodium dodecyl sulfate solution is an effective between-run rinse for capillary electrophoresis of samples in biological matrices | |
CA2527351C (fr) | Procede d`analyse de l`hemoglobine par electrophorese capillaire, trousse pour electrophorese capillaire et utilisation de ralentisseur de flux dans un tel procede | |
CN105806919A (zh) | 试样的分析方法及其中所用的溶液 | |
Chen et al. | Simultaneous separation of sixteen positional and optical isomers of the tryptophan family by ligand-exchange micellar electrokinetic chromatography | |
EP2880434A1 (fr) | Procede de separation de molecules et cellules biologiques en solution | |
US7250100B2 (en) | Two dimensional electrophoresis cassette | |
EP1207954A2 (fr) | Compositions utilisables pour l'hydratation d'un support d'electrophorese, pour l'electrophorese de zone | |
CN106248763A (zh) | 一种在纸基分析装置上等电聚焦和分离两性物质的方法 | |
EP2080020B1 (fr) | Électrophorèse capillaire bi - ou multidimensionnelle au sein d'un unique capillaire | |
Rizvi et al. | Polymeric alkenoxy amino acid surfactants: III. Chiral separations of binaphthyl derivatives | |
US7837848B2 (en) | Bidimensional separation by means of capillary electrophoresis carried out in a single capillary | |
WO2017065096A1 (fr) | Gel de polyacrylamide | |
Gianazza et al. | Which electrodic solutions for immobilized pH gradients? | |
EP1258724A1 (fr) | Procédé d'électrophorèse capillaire en solution libre à pH alcalin | |
Lin et al. | Enantioseparation of phenothiazines in cyclodextrin‐modified capillary zone electrophoresis using sulfated cyclodextrins as chiral selectors | |
FR2668604A1 (fr) | Procede pour preparer une colonne capillaire, emplie d'un gel forme par polymerisation progressant dans l'espace a l'aide d'un amorceur migrant. | |
EP1204862B1 (fr) | Methode de separation, d'identification et de quantification des isophosphatases alcalines par electrophorese | |
Gaillon et al. | New pseudo-stationary phases for electrokinetic capillary chromatography: Complexes between bovine serum albumin and sodium dodecyl sulfate | |
WO2006037930A1 (fr) | Procede d'obtention d'un support pour electrophoserese incluant des cyclodextrat ines | |
Kumar | On the contribution of haemolymph to the salivary proteins of the red cotton bug, Dysdercus koenigii F.(Heteroptera, Pyrrhocoridae) | |
ITMI932527A1 (it) | Procedimento e dispositivo per la separazione elettroforetica di dna | |
FR2804759A1 (fr) | Procede de determination de l'endommagement de la peau et des tissus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2001 561425 Kind code of ref document: A Format of ref document f/p: F |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2001907836 Country of ref document: EP |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWP | Wipo information: published in national office |
Ref document number: 2001907836 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2001907836 Country of ref document: EP |